considered medically necessary for members meeting the following conditions:
unresectable or metastatic melanoma AND
BRAF V600E or
V600K mutation positive AND
be used in combination with Zelboraf (Vemurafenib) AND
ventricular ejection fraction has been determined AND
liver laboratory tests, CPK, and creatinine levels have been obtained AND
pregnancy and contraceptive counseling have been provided.